All of our offerings
All of our offerings
Curis, Inc.
Registered Direct and Concurrent Private Placement
$12,100,000
Placement Agent
October 2024
IN8bio, Inc.
Financial Advisor
Financial Advisor
October 2024
Beyond Air
Private Placement
$20,600,000
Co-Placement Agent
September 2024
Adaptin Bio
Seed Financing
Convertible Bridge Notes
$1,500,000
Exclusive Placement Agent
August 2024
PD Theranostics – Ovation.io
Private Placement and Concurrent Merger
$9,500,000
Exclusive Placement Agent
August 2024
Hepion Pharmaceuticals
Unsecured Non-Convertible Note
$2,900,000
Financial Advisor
July 2024
Algorithm Sciences
Spin Out-Infusyn Therapeutics
$5,000,000
Sole Advisor
June 2024
Applied DNA Sciences
Follow-On Offering
$12,000,000
Co-Placement Agent
May 2024
.
AerWave Medical
Introducing Broker
$5,000,000
Lead Manager
May 2024
Soleno Therapeutics
Follow-On Offering
$138,000,000
Lead Manager
May 2024
Beyond Air
Registered Direct Offering
$16,000,000
Co-Placement Agent
March 2024
BiomX, Inc.
Private Placement
$50,000,000
Placement Agent
March 2024
Viking Therapeutics
Follow-On Offering
$632,500,000
Co-Manager
March 2024
Oragenics, Inc.
Follow-On Offering
$2,100,000
Joint Book-Running Manager
March 2024
Evoke Pharma
Follow-On Offering
$7,500,000 of up to $30,000,000
Joint Book-Runner
February 2024
Perfect Moment
Initial Public Offering
$8,000,000
Joint Book-Runner
February 2024
Infusyn Therapeutics
Series D Preferred
$4,000,000
Introducing Broker
January 2024
Infusyn Therapeutics
Series D Preferred
$4,000,000
Introducing Broker
January 2024
Beyond Air
Advisory Services
January 2024
Beyond Air
Advisory Services
January 2024
EyePoint Pharmaceuticals
Follow-On Offering
Common Stock
$230,000,000
Co-Manager
December 2023
EyePoint Pharmaceuticals
Follow-On Offering
Common Stock
$230,000,000
Co-Manager
December 2023
Soleno Therapeutics
Common Stock &
Concurrent Private Placement
$129,000,000
Lead Manager
October 2023
Soleno Therapeutics
Common Stock &
Concurrent Private Placement
$129,000,000
Lead Manager
October 2023
BioSig
Technologies
Pipe Transaction
$2,500,000
At the Market Offering
May 2023
BioSig
Technologies
Pipe Transaction
$2,500,000
At the Market Offering
May 2023
PD Theranostics
Series A Financing
$3,000,000
Exclusive Placement Agent
April 2023
PD Theranostics
Series A Financing
$3,000,000
Exclusive Placement Agent
April 2023
Service Robotics Inc.
Secured Convertible Debenture
$3,000,000
Introducing Broker
April 2023
Service Robotics Inc.
Secured Convertible Debenture
$3,000,000
Introducing Broker
April 2023
Viking Therapeutics
Follow-On Offering
$287,500,000
Co-Manager
March 2023
Viking Therapeutics
Follow-On Offering
$287,500,000
Co-Manager
March 2023
Guerilla RF, Inc
PIPE Transaction
$9,200,000
Exclusive Placement Agent
February 2023
Guerilla RF, Inc
PIPE Transaction
$9,200,000
Exclusive Placement Agent
February 2023
Hoth Therapeutics
PIPE Transaction
$10,000,000
Financial Advisor
February 2023
Hoth Therapeutics
PIPE Transaction
$10,000,000
Financial Advisor
February 2023
BioSig Technologies
PIPE Transaction
$7,300,000
Introducing Broker
January 2023
BioSig Technologies
PIPE Transaction
$7,300,000
Introducing Broker
January 2023
NLS Pharmaceutics
Private Placement
$10,000,000 of up to $30,000,000
Investor: BVF Partners L.P.
Exclusive Introducing Broker
December 2022
NLS Pharmaceutics
Private Placement
$10,000,000 of up to $30,000,000
Investor: BVF Partners L.P.
Exclusive Introducing Broker
December 2022
NLS Pharmaceutics
Private Placement
$4,000,000
Sole Placement Agent
October 2022
NLS Pharmaceutics
Private Placement
$4,000,000
Sole Placement Agent
October 2022
Perfect Moment
Private Placement
$6,000,000
Exclusive Placement Agent
October 2022
Perfect Moment
Private Placement
$6,000,000
Exclusive Placement Agent
October 2022
Silo Pharma
Follow-On Offering
$5,750,000
Sole Book Runner
September 2022
Silo Pharma
Follow-On Offering
$5,750,000
Sole Book Runner
September 2022
Amesite, Inc
Registered Direct Offering
$2,300,000
Sole Placement Agent
August 2022
Amesite, Inc
Registered Direct Offering
$2,300,000
Sole Placement Agent
August 2022
BioSig Technologies
Follow-On Offering
Common Stock
$3,500,000
Sole Book-Runner
June 2022
BioSig Technologies
Follow-On Offering
Common Stock
$3,500,000
Sole Book-Runner
June 2022
Perfect Moment
Secured Convertible Note
$10,000,000
Exclusive Placement Agent
June 2022
Perfect Moment
Secured Convertible Note
$10,000,000
Exclusive Placement Agent
June 2022
Odyssey Group International Inc.
PIPE Common Stock
and Warrants
$1,420,430
Exclusive Placement Agent
May 2022
Odyssey Group International Inc.
PIPE Common Stock
and Warrants
$1,420,430
Exclusive Placement Agent
May 2022
Soleno Therapeutics
Follow-On Offering
Common Stock and Warrants
$15,000,000
Co-Manager
March 2022
Soleno Therapeutics
Follow-On Offering
Common Stock and Warrants
$15,000,000
Co-Manager
March 2022
Amesite, Inc.
Follow-On Offering
Common Stock
$3,000,000
Sole-Book Runner
February 2022
Amesite, Inc.
Follow-On Offering
Common Stock
$3,000,000
Sole-Book Runner
February 2022
Cohen & Steers
Initial Public Offering
Common Stock
$367,886,900
Initial Public Offering
February 2022
Cohen & Steers
Initial Public Offering
Common Stock
$367,886,900
Initial Public Offering
February 2022
Pimco Access Income Fund
Initial Public Offering
Common Stock
$866,000,000
Co-Manager
January 2022
Pimco Access Income Fund
Initial Public Offering
Common Stock
$866,000,000
Co-Manager
January 2022
MEI Pharma
PIPE Transaction
Follow-On Offering
Common Stock
$52,325,000
Co-Manager
December 2021
MEI Pharma
PIPE Transaction
Follow-On Offering
Common Stock
$52,325,000
Co-Manager
December 2021
Cingulate Inc.
Initial Public Offering
Common Stock and Warrants
$25,000,000
Co-Lead Bookrunner
December 2021
Cingulate Inc.
Initial Public Offering
Common Stock and Warrants
$25,000,000
Co-Lead Bookrunner
December 2021
Voltron Therapeutics
Series B Preferred Offering
$4,000,000
Exclusive Placement Agent
November 2021
Voltron Therapeutics
Series B Preferred Offering
$4,000,000
Exclusive Placement Agent
November 2021
EyePoint Pharmaceuticals
Follow-On Offering
Common Stock
$115,000,000
Financial Advisor
November 2021
EyePoint Pharmaceuticals
Follow-On Offering
Common Stock
$115,000,000
Financial Advisor
November 2021
Guggenheim Active Allocation Fund
Initial Public Offering
Common Stock
$655,000,000
Co-Manager
November 2021
Guggenheim Active Allocation Fund
Initial Public Offering
Common Stock
$655,000,000
Co-Manager
November 2021
aTyr Pharma Inc.
Follow-On Offering
Common Stock
$86,250,000
Lead Manager
September 2021
aTyr Pharma Inc.
Follow-On Offering
Common Stock
$86,250,000
Lead Manager
September 2021
BlackRock ESG Capital Alloc. Trust
Initial Public Offering
Common Stock
$2,040,000,000
Co-Manager
September 2021
BlackRock ESG Capital Alloc. Trust
Initial Public Offering
Common Stock
$2,040,000,000
Co-Manager
September 2021
BioSig Technologies
Follow-On Offering
Common Stock
$10,000,000
Sole Book Runner
July 2021
BioSig Technologies
Follow-On Offering
Common Stock
$10,000,000
Sole Book Runner
July 2021
Perfect Moment
Private Placement
$6,000,000
Exclusive Placement Agent
May 2021
Perfect Moment
Private Placement
$6,000,000
Exclusive Placement Agent
May 2021
Aldeyra Therapeutics
Follow-On Offering
Common Stock
$125,000,000
Co-Manager
April 2021
Aldeyra Therapeutics
Follow-On Offering
Common Stock
$125,000,000
Co-Manager
April 2021
Algorithm Sciences
Series B Offering
$5,000,000
Co-Manager
April 2021
Algorithm Sciences
Series B Offering
$5,000,000
Co-Manager
April 2021
iCAD Inc.
Follow-On Offering
Common Stock
$25,000,000
Co-Manager
March 2021
iCAD Inc.
Follow-On Offering
Common Stock
$25,000,000
Co-Manager
March 2021
Blue Stem Properties, LLC
Exclusive Placement Agent
$11,000,000
March 2021
Blue Stem Properties, LLC
Exclusive Placement Agent
$11,000,000
March 2021
Aerwave Medical
Series A Offering
$4,000,000
Exclusive Placement Agent
February 2021
Aerwave Medical
Series A Offering
$4,000,000
Exclusive Placement Agent
February 2021
EyePoint Pharma
Follow-On Offering
Common Stock
$115,000,000
Financial Advisor
February 2021
EyePoint Pharma
Follow-On Offering
Common Stock
$115,000,000
Financial Advisor
February 2021
Evoke Pharma
Follow-On Offering
Common Stock
$14,375,000
Sole Book-Runner
January 2021
Evoke Pharma
Follow-On Offering
Common Stock
$14,375,000
Sole Book-Runner
January 2021
Affimed
Follow-On Offering
Common Stock
$14,375,000
Co-Manager
January 2021
Affimed
Follow-On Offering
Common Stock
$14,375,000
Co-Manager
January 2021
Curis, Inc.
Registered Direct and Concurrent Private Placement
$12,100,000
Placement Agent
October 2024
IN8bio, Inc.
Advisory Services
Financial Advisor
October 2024
Beyond Air
Private Placement
$20,600,000
Co-Placement Agent
September 2024
Adaptin Bio
Seed Financing
Convertible Bridge Notes
$1,500,000
Exclusive Placement Agent
August 2024
PD Theranostics – Ovation
Private Placement and Concurrent Merger
$9,500,000
Exclusive Placement Agent
August 2024
Hepion
Pharmaceuticals
Unsecured Non-Convertible Note
$2,900,000
Financial Advisor
July 2024
Algorithm
Sciences
Spin Out – Infusyn Therapeutics
$5,000,000
Sole Advisor
June 2024
Applied DNA Sciences
Follow-On Offering
$12,000,000
Co-Placement Agent
May 2024
.
AerWave Medical
Convertible Debentures
$5,000,000
Introducing Broker
May 2024
Soleno Therapeutics
Follow-On Offering
$158,700,000
Lead Manager
May 2024
Beyond Air
Registered Direct Offering
$16,000,000
Co-Placement Agent
March 2024
BiomX, Inc.
Private Placement
$50,000,000
Placement Agent
March 2024
Viking Therapeutics
Follow-On Offering
$632,500,000
Co-Manager
March 2024
Oragenics, Inc.
Follow-On Offering
$2,100,000
Joint Book-Running Manager
March 2024
Evoke Pharma
Follow-On Offering
$7,500,000 of up to $30,000,000
Joint Book-Runner
February 2024
Perfect Moment
Initial Public Offering
$8,000,000
Joint Book-Runner
February 2024
Infusyn Therapeutics
Series D Preferred
$4,000,000
Introducing Broker
January 2024
Beyond Air
Advisory Services
January 2024
EyePoint Pharmaceuticals
Follow-On Offering
Common Stock
$230,000,000
Co-Manager
December 2023
MAIA Biotechnology
Common Stock &
Concurrent Private Placement
Financial Advisor
November 2023
Soleno Therapeutics
Common Stock &
Concurrent Private Placement
$129,000,000
Lead Manager
October 2023
Cingulate
Advisory Services
September 2023
MAIA Biotechnology
Advisory Services
August 2023
BioSig
Technologies
Pipe Transaction
$2,500,000
At the Market Offering
May 2023
PD Theranostics
Series A Financing
$3,000,000
Exclusive Placement Agent
April 2023
Service Robotics Inc.
Secured Convertible Debenture
$3,000,000
Introducing Broker
April 2023
Viking Therapeutics
Follow-On Offering
$287,500,000
Co-Manager
March 2023
Guerilla RF, Inc
PIPE Transaction
$9,200,000
Exclusive Placement Agent
February 2023
Hoth Therapeutics
PIPE Transaction
$10,000,000
Financial Advisor
February 2023
BioSig Technologies
PIPE Transaction
$7,300,000
Introducing Broker
January 2023
NLS Pharmaceutics
Private Placement
$10,000,000 of up to $30,000,000
Investor: BVF Partners L.P.
Exclusive Introducing Broker
December 2022
NLS Pharmaceutics
Private Placement
$4,000,000
Sole Placement Agent
October 2022
Perfect Moment
Private Placement
$6,000,000
Exclusive Placement Agent
October 2022
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Silo Pharma
Follow-On Offering
$5,750,000
Sole Book Runner
September 2022
Amesite, Inc
Registered Direct Offering
$2,300,000
Sole Placement Agent
August 2022
BioSig Technologies
Follow-On Offering
Common Stock
$3,500,000
Sole Book-Runner
June 2022
Perfect Moment
Secured Convertible Note
$10,000,000
Exclusive Placement Agent
June 2022
Odyssey Group International Inc.
PIPE Common Stock
and Warrants
$1,420,430
Exclusive Placement Agent
May 2022
Soleno Therapeutics
Follow-On Offering
Common Stock and Warrants
$15,000,000
Co-Manager
March 2022
Amesite, Inc.
Follow-On Offering
Common Stock
$3,000,000
Sole-Book Runner
February 2022
Cohen & Steers
Initial Public Offering
Common Stock
$367,886,900
Initial Public Offering
February 2022
Pimco Access Income Fund
Initial Public Offering
Common Stock
$866,000,000
Co-Manager
January 2022
MEI Pharma
PIPE Transaction
Follow-On Offering
Common Stock
$52,325,000
Co-Manager
December 2021
Cingulate Inc.
Initial Public Offering
Common Stock and Warrants
$25,000,000
Co-Lead Bookrunner
December 2021
Voltron Therapeutics
Series B Preferred Offering
$4,000,000
Exclusive Placement Agent
November 2021
EyePoint Pharmaceuticals
Follow-On Offering
Common Stock
$115,000,000
Financial Advisor
November 2021
Guggenheim Active Allocation Fund
Initial Public Offering
Common Stock
$655,000,000
Co-Manager
November 2021
aTyr Pharma Inc.
Follow-On Offering
Common Stock
$86,250,000
Lead Manager
September 2021
BlackRock ESG Capital Alloc. Trust
Initial Public Offering
Common Stock
$2,040,000,000
Co-Manager
September 2021
BioSig Technologies
Follow-On Offering
Common Stock
$10,000,000
Sole Book Runner
July 2021
Perfect Moment
Private Placement
$6,000,000
Exclusive Placement Agent
May 2021
Aldeyra Therapeutics
Follow-On Offering
Common Stock
$125,000,000
Co-Manager
April 2021
Algorithm Sciences
Series B Offering
$5,000,000
Co-Manager
April 2021
iCAD Inc.
Follow-On Offering
Common Stock
$25,000,000
Co-Manager
March 2021
Blue Stem Properties, LLC
Exclusive Placement Agent
$11,000,000
March 2021
Aerwave Medical
Series A Offering
$4,000,000
Exclusive Placement Agent
February 2021
EyePoint Pharma
Follow-On Offering
Common Stock
$115,000,000
Financial Advisor
February 2021
Evoke Pharma
Follow-On Offering
Common Stock
$14,375,000
Sole Book-Runner
January 2021
Affimed
Follow-On Offering
Common Stock
$14,375,000
Co-Manager
January 2021
Curis Inc.
Follow-On Offering
Common Stock
$169,625,000
Lead Manager
December 2020
Delcath Systems
Follow-On Offering
Common Stock
$22,247,000
Financial Advisor
December 2020
Amesite, Inc
Initial Public Offering
Common Stock
$15,000,000
Sole Book Runner
September 2020
PD Theranostics
Series A Offering
$3,000,000
Exclusive Placement Agent
August 2020
Arcturus Therapeutics
Follow-On Offering
Common Stock
$173,000,000
Financial Advisor
July 2020
Voltron Therapeutics
Series A Preferred Offering
$3,500,000
Exclusive Placement Agent
June 2020
Soleno Therapeutics
Follow-On Offering
Common Stock
$50,000,000
Co-Manager
June 2020
Amesite Inc
Exclusive Placement Agent
$1,000,000
May 2020
ViralClear Pharmaceuticals
Private Placement
Common Stock
$10,000,000
Introducing Broker
May 2020
Delcath Systems
Follow-On Offering
Common Stock
$22,000,000
Co-Lead Manager
May 2020
Arcturus Therapeutics
Follow-On Offering
Common Stock
$70,000,000
Financial Advisor
April 2020
Hoth Therapeutics
Follow-On Offering
Common Stock
$5,000,000
Sole-Book Runner
March 2020
Ziopharm Oncology
Follow-On Offering
Common Stock
$90,000,000
Co-Manager
February 2020
Algorithm Sciences
Series A Offering
$3,500,000
Exclusive Placement Agent
February 2020
Biosig Technologies
Follow-On Offering
Common Stock
$10,000,000
Sole Book-Runner
February 2020
EyePoint Pharmaceuticals
Follow-On Offering
Common Stock
$21,800,000
Co-Manager
February 2020
Beyond Air
Follow-On Offering
Common Stock
$10,500,000
Financial Advisor
December 2019
Affimed
Follow-On Offering
Common Stock
$34,500,000
Co-Manager
November 2019
Molecular Templates
Follow-On Offering
Common Stock
$50,000,000
Financial Advisor
November 2019
Soleno Therapeutics
Follow-On Offering
Common Stock
$15,400,000
Co-Manager
October 2019
Noxopharm, Ltd
Funding Facility
$26,000,000
Sole Financial Advisor
July 2019
Icad, Inc
Follow-On Offering
Common Stock
$9,000,000
Financial Advisor
June 2019
Athenex, Inc
Block Trade
$20,000,000
Sole Broker
April 2019
EyePoint Pharmaceuticals
Follow-On Offering
Common Stock
$20,000,000
Co-Manager
March 2019
Hoth Therapeutics
Initial Public Offering
Common Stock
$7,000,000
Sole Book Runner
February 2019
Taiwan Liposome Company
Initial Public Offering
Common Stock
$21,750,000
Co-Manager
November 2018
Tiziana Life Sciences
Initial Public Offering
Common Stock
$7,000,000
Sole Book Runner
November 2018
Molecular Templates, Inc
Follow-On Offering
Common Stock
$45,100,000
Lead Manager
September 2018
Viking Therapeutics
Follow-On Offering
Common Stock
$175,800,000
Financial Advisor
September 2018
Aldeyra Therapeutics
Follow-On Offering
Common Stock
$72,187,500
Co-Manager
September 2018
BioSig Technologies
PIPE Transaction
Common Stock
$6,000,000
Introducing Broker
August 2018
Aridis Pharmaceuticals
Initial Public Offering
Common Stock
$26,000,000
Co-Manager
August 2018
WatchTower Investments, LLC
Member Interests
$16,348,970
August 2018
Athenex, Inc
PIPE Transaction
Common Stock
$100,000,000
Exclusive Placement Agent
July 2018
Viking Therapeutics
Follow-On Offering
Common Stock
$78,000,000
Financial Advisor
June 2018
Sesen Bio
Follow-On Offering
Common Stock
$48,000,000
Financial Advisor
May 2018
MEI Pharma
PIPE Transaction
Common Stock and Warrants
$75,000,000
Co-Placement Agent
May 2018
Sesen Bio
Registered Direct
Common Stock and Warrants
$10,000,000
Exclusive Placement Agent
March 2018
Gemphire
Follow-On Offering
Common Stock
$22,000,000
Co-Manager
February 2018
Affimed
Follow-On Offering
Common Stock
$23,000,000
Financial Advisor
February 2018
Hoth Therapeutics
Private Placement
Series A Preferred Warrants
$3,102,480
Exclusive Placement Agent
February 2018
AIT Therapeutics
PIPE Transaction
Warrants
$9,820,154.54
Exclusive Placement Agent
February 2018
Athenex, Inc
Follow-On Offering
Common Stock
$65,575,000
Co-Manager
January 2018
Social T Partners
Member Interests
$16,137,216
February 2011 - December 2017
Fennec Pharmaceuticals
Follow-On Offering
Common Stock
$20,000,000
Financial Advisor
December 2017
Cytori Therapeutics
Rights Offering
Convertible Preferred
Common Stock
$10,000,000
Financial Advisor
November 2017
Onconova Therapeutics
Registered Direct
Common Stock
$1,380,000
Sole Placement Agent
November 2017
ADMA Biologics
Follow-On Offering
Common Stock
$36,500,000
Financial Advisor
November 2017
Flexion Therapeutics
Follow-On Offering
Common Stock
$122,400,000
Financial Advisor
October 2017
Asterias Biotherapeutics
Registered Direct
Common Stock
$10,400,000
Financial Advisor
October 2017
US Gold Corporation
Confidentially Marketed Public Offering
Common Stock
$2,500,000
Sole Book Runner
October 2017
Hoth Therapeutics
Private Placement
Common Stock
$2,037,000
Exclusive Placement Agent
September 2017
SearchLight Investments, LLC
Member Interests
$17,382,225
September 2017
MabVax Therapeutics, Inc.
Registered Direct
Common Stock
$2,000,000
Sole Placement Agent
September 2017
Aldeyra Therapeutics
Follow-On Offering
Common Stock
$28,800,000
Lead Manager
September 2017
Cooltech Holding Corp.
Private Placement
Common Stock
$5,688,055
Exclusive Placement Agent
June 2017
Spherix, Inc.
Follow-On Offering
$2,500,000
Sole Book Runner
June 2017
Flexion Therapeutics
Convertible Note
$175,000,000
Financial Advisor
May 2017
MabVax Therapeutics, Inc.
Convertible Note
Common and Preferred Stock
$4,100,000
Sole Book-Runner
May 2017
Repros Therapeutics
Confidentially Marketed Public Offering
Common Stock and Warrants
$3,000,000
Sole Book-Runner
May 2017
Onconova Therapeutics
Confidentially Marketed Public Offering
Common Stock
$5,963,517
Sole Book-Runner
April 2017
Gemphire
PIPE Transaction
Common Stock & Warrants
$12,500,000
Co-Manager
March 2017
Therapix Biosciences
Initial Public Offering
Common Stock
$13,800,000
Sole Book Runner
March 2017
AIT Therapeutics
PIPE Transaction
Common Stock and Warrants
$10,200,000
Placement Agent
March 2017
BioSig Technologies
PIPE Transaction
Common Stock and Warrants
$4,349,954
Exclusive Placement Agent
March 2017
Function(x), Inc.
Follow-On Offering
Common Stock
$5,000,000
Joint Book Runner
February 2017
Aldeyra Therapeutics
Follow-On Offering
Common Stock
$10,000,000
Lead Manager
February 2017
Medovex Corporation
PIPE Transaction
Common Stock & Warrants
$3,022,000
Exclusive Placement Agent
February 2017
Affimed
Follow-On Offering
Common Stock
$19,170,000
Financial Advisor
January 2017
Pershing Gold Corporation
Confidentially Marketed Public Offering
Common Stock
$7,500,000
Lead Underwriter
December 2016
Towerstream Corporation
Confidentially Marketed Public Offering
Common Stock
$4,000,000
Sole Book Runner
November 2016
US Gold Corporation
Private Placement
Common Stock
$12,000,000
Exclusive Placement Agent
October 2016
FTE Networks, Inc.
PIPE Transaction
Common Stock & Warrants
$2,990,000
Exclusive Placement Agent
October 2016
Protea Biosciences Group, Inc.
Convertible Debenture
$2,990,000
Exclusive Placement Agent
September 2016
Spherix, Inc.
Confidentially Marketed Public Offering
Common Stock
$2,500,000
Sole Book-Runner
August 2016
MabVax Therapeutics, Inc
Follow-On Offering
Common Stock & Warrants
$9,438,750
Sole Book-Runner
August 2016
Alimera Sciences
Follow-On Offering
Common Stock
$25,000,000
Co-Manager
August 2016
ImmunoCellular
Follow-On Offering
Common Stock
$7,400,000
Lead Manager
August 2016
Gemphire
Initial Public Offering
Common Stock
$30,000,000
Co-Manager
August 2016
Flexion
Follow-On Offering
Common Stock
$77,000,000
Co-Manager
June 2016
PhaseRx
Initial Public Offering
Common Stock
$18,500,000
Book Runner
May 2016
ADMA Biologics
Follow-On Offering
Common Stock
$14,200,000
Financial Advisor
April 2016
Medovex Corporation
PIPE Transaction
Common Stock & Warrants
$1,398,033
Placement Agent
April 2016
Regenmed Therapeutics
Sale of Company
Undisclosed Amount
Financial Advisory
March 2016
Pershing Gold Corporation
PIPE Transaction
Common Stock
$6,890,000
Exclusive Placement Agent
March 2016
ContraVir Pharmaceuticals
Follow-On Offering
Common Stock
$7,000,000
Sole Book-Runner
March 2016
Red Zone Investments, LLC
Member Interests
$11,926,825
March 2016
Aeolus Pharmaceuticals
PIPE Transaction
Common Stock
$6,750,000
Exclusive Placement Agent
December 2015
Cerecor, Inc.
Initial Public Offering
Common Stock & Warrants
$26,000,000
Lead Manager
October 2015
MabVax Therapeutics, Inc.
Follow-On Offering
Common Stock & Warrants
$2,750,000
Sole Book-Runner
October 2015
ContraVir Pharmaceuticals
Follow-On Offering
Common Stock & Warrants
$15,000,000
Sole Book-Runner
October 2015
Sevion Therapeutics
PIPE Transaction
Common Stocks & Warrants
$7,325,217
Exclusive Placement Agent
July 2015
AirBase Technology Partners, LLC
Member Interests
$19,124,663
July 2015
Pre-Flight Partners, LLC
Member Interests
$10,841,676
October 2011 - July 2015
Bluebird Investment Partners
Member Interests
$13,848,670
April 2012 - June 2015
Face-Off Partners II, LLC
Member Interests
$22,012,097
September 2010 - June 2015
Actinium Pharmaceuticals
Registered Direct
$5,000,000
Exclusive Placement Agent
June 2015
AirLift Investments, LLC
Member Interests
$40,877,660
May 2015
Viking Therapeutics
Member Interests
Initial Public Offering
$40,877,660
Sole Book-Runner
May 2015
Aldeyra Therapeutics
Follow-On Offering
Common Stock
$20,250,000
Co-Manager
May 2015
BioSig Technologies
Follow-On Offering
Common Stock
$4,009,000
Exclusive Placement Agent
April 2015
Stay In Touch